NCT00055718 · Interventional trial
Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
Overall registry status Completed
Phase 2
Conditions Drug/Agent Toxicity by Tissue/Organ, Leukemia
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory